This randomized clinical trial compares the effects of suppressive treatment for 12 months with oral valacyclovir on the prevalence, severity, and duration of postherpetic neuralgia vs placebo at 12 and 18 months in participants with herpes zoster ophthalmicus.
Visionary News & Insightful Strategy
Footer
A RETINA-SPECIFIC ORGANIZATION
It’s clearly an advantage to work with a consulting group that’s focused on your industry. The team at Retina Consultant has over 50 years of retina-specific experience in healthcare business, practice management, marketing & operations.
We’ve got our eyes on working with the best retina groups and vendors in the industry.
See the best; get in touch.
Recent
- Australian Society of Ophthalmologists welcomes Katrina Ronne as the first woman in its CEO role
- PER launches Retina Resource, an anti-VEGF education and information tool
- Genetic risk for glaucoma increases with age
- Anat Loewenstein comments on the recent FDA approval of revakinagene taroretcel-lwey (ENCELTO) for macular telangiectasia type 2 treatment
- Woman presents with morning unilateral vision blackouts
Leave a Reply